What blows my mind about these clinical trials is that the truth is always going to come out if the drug goes to market. And for big pharma, that's the goal--g

What blows my mind about these clinical trials is that the truth is always going to come out if the drug goes to market. And for big pharma, that's the goal--get the drug to market (and the largest market possible). While you can hide bad results when n is small. i.e. just re-run the trial with another or smaller n. However, when n gets large as the drug comes to market, there is nowhere to hide. The negative effects will become obvious and compelling as the sample size grows. How do they think they can hide this?